-
Mashup Score: 0
The patient-administered device, which uses a mild electrical current to improve depressive symptoms, showed promising results in a clinical trial.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Researchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer.
Source: News-Medical.netCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0FDA device center’s 2022 report reveals 37% drop in annual breakthrough designations - 1 year(s) ago
The annual report also highlighted the CDRH’s work on pulse oximeters, Philips’ recall of sleep and respiratory devices, cybersecurity and artificial intelligence.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Burning Rock (Nasdaq:BNR) announced today that the FDA granted breakthrough device designation to its OverC blood test.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Datar Cancer Genetics announced that it received FDA breakthrough device designation for its TriNetra-Glio blood test.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Click Therapeutics wins FDA breakthrough nod for migraine-treating digital therapeutic - 1 year(s) ago
Click Therapeutics announced that it received FDA breakthrough device designation for its CT-132 prescription digital therapeutic (PDT).
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0FDA efforts to prioritize medtech innovation pay dividends - 2 year(s) ago
Even though the U.S. is a larger market, many companies looked to Europe to win regulatory approval for their medtech innovation efforts.
Source: Medical Design and OutsourcingCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Sinaptica Therapeutics obtains FDA Breakthrough Device Designation for Alzheimer's treatment - 2 year(s) ago
The neurostimulation device, which is currently for investigational use only, aims to treat cognitive and functional decline in Alzheimer’s patients.
Source: MobiHealthNewsCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0FDA starts advisory program pilot to reduce ‘valley of death’ risk for medical devices - 2 year(s) ago
A plan to ensure more medical devices pass from testing to clinical application aims to help dozens of devices through the approval process each year.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2
–
Source: researchamerica.6connex.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
.@soomamedical #neuromodulation therapy for #depression granted #FDA #breakthrough status | #mentalhealth https://t.co/9jUJHRjQKk